Endometrial Cancer Trial, Recruiting NCT07435623 Sponsor: Tata Memorial Hospital Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07435623
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be older than 18 years of age at the time of your diagnosis.
  • You must have been diagnosed with cervical cancer or endometrial (uterine) cancer, confirmed by a tissue sample test.
  • You must have received a specific type of radiation treatment (called IMRT) and/or internal radiation (called brachytherapy) after surgery, given at TMH or ACTREC hospitals.
  • Your medical follow-up records and information must be available.

Who may not be able to join:

  • You may not be eligible if your treatment records are incomplete or missing important details.
  • You may not be eligible if cancer was still present in your body after your surgery.
  • You may not be eligible if you were treated for cancer that came back (recurred) after your surgery.
  • You may not be eligible if you did not attend your follow-up appointments after treatment.
  • You may not be eligible if you have a condition that weakens your immune system (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02227405000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tata Memorial Hospital
Registry
ClinicalTrials.gov
Start date
10 May 2025
Est. completion
10 July 2025

Where this trial is recruiting

🇮🇳 India

Primary endpoints

3 years incidence of ≥ grade II Gastrointestinal & Genitourinary toxicities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov